Ballerup, Denmark

Tine Marianne Duus

USPTO Granted Patents = 2 

 

Average Co-Inventor Count = 3.7

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2020-2022

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Tine Marianne Duus: Innovator in Pharmaceutical Compounds

Introduction

Tine Marianne Duus is a notable inventor based in Ballerup, Denmark. She has made significant contributions to the field of pharmaceuticals, particularly in the development of novel compounds with therapeutic applications. With a total of 2 patents, her work focuses on innovative methods for preparing important chemical compounds.

Latest Patents

Duus's latest patents include groundbreaking methods for the preparation of 1,3-benzodioxole heterocyclic compounds. This invention relates to novel techniques that produce these compounds, which are useful as PDE4 inhibitors. Another significant patent involves amino-imidazopyridine derivatives as Janus kinase inhibitors, which are aimed at treating autoimmune diseases. This invention encompasses compounds that can be used in therapy, along with pharmaceutical compositions that include these compounds.

Career Highlights

Throughout her career, Tine Marianne Duus has worked with prominent companies in the pharmaceutical industry, including Union Therapeutics A/S and Leo Pharma A/S. Her expertise in the field has allowed her to contribute to the development of innovative therapeutic solutions.

Collaborations

Duus has collaborated with notable colleagues such as Allan Carsten Dahl and Gitte Holm Jensen, enhancing her research and development efforts in the pharmaceutical sector.

Conclusion

Tine Marianne Duus is a distinguished inventor whose work in pharmaceutical compounds has the potential to impact the treatment of various diseases. Her innovative patents and collaborations reflect her commitment to advancing medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…